Visitors - Health
Siloam Hospitals
Siloam Hospitals is the premier private hospital group that comprises seven hospitals, providing world class healthcare to both domestic and overseas patients. With a total capacity of 1,227 beds, Siloam Hospitals are equipped with operating theatres, maternity care, pediatric care, and outpatient facilities.
Continuously investing in new projects, Siloam Hospitals’ investment in research, education, and the latest state-of-the art medical technology and equipment is a reflection of its pioneering efforts to improve the standard of medical care available in Indonesian. Likewise the collaboration with international institutions and consultants, enables us to improve the capacity of human skills on par with international standards.
Siloam Hospitals Lippo Village is located at the vicinity of Lippo Village township in the west of Jakarta. In addition to providing a comprehensive range of medical specialties, Siloam Hospitals Lippo Village houses two Centres of Excellence in neuroscience and cardiology. Siloam Hospitals Lippo Village is the first Indonesian hospital to attain the prestigious US-based Joint Commission International (“JCI”) accreditation – the world’s leading internationally recognised hospital accreditation award, putting it in the same league as other leading hospitals in the region.
For further info, please click this.
Mochtar Riady Institute for Nanotechnology
With a population of over 220 Million, public health is one serious concern in Indonesia. Cancer in particular is a leading cause of deaths. Early diagnosis and effective treatment are keys to the control and management of this complex systemic disease, in which the research in Indonesia is still in its infancy.
As part of Lippo Medical and Health Program, that includes the Faculty of Medicine Pelita Harapan University, Siloam Hospitals and the Mochtar Riady Comprehensive Cancer Center (MRCCC), Mochtar Riady Institute for Nanotechnology (MRIN) is established in 2006 to support cancer research in Indonesia using both genomic and proteomic approaches.
For further info, please click this.